top of page

ASAP 340B Encouraged by U.S. Senators’ 340B Fact-Finding

Request for Information is Important Step Toward Updating the Federal Program Aimed at Helping Underserved Patients Access Affordable Medicines

FOR IMMEDIATE RELEASE

June 16, 2023

Washington, D.C. – The Alliance to Save America’s 340B Program (ASAP 340B) is encouraged by Senator John Thune (R-SD), Senator Debbie Stabenow (D-MI), Senator Shelley Moore Capito (R-WV), Senator Tammy Baldwin (D-WI), Senator Jerry Moran (R-KS), and Senator Benjamin Cardin (D-MD) for issuing a Request for Information (RFI) to subject matter experts and stakeholders regarding the 340B Drug Pricing Program (340B program). Community Health Centers, patient, provider and consumer advocates, and leaders from the biopharmaceutical industry recently established ASAP 340B to facilitate open dialogue amongst stakeholders and put forth a comprehensive set of policy principles that realign the 340B program in the interest of patients and true safety-net providers. ASAP 340B looks forward to responding to the RFI.

The following statement can be attributed to Thomas Johnson, ASAP 340B Executive Director:

“Today, Senate leaders have taken a key step toward transparency, accessibility, accountability, and certainty for the 340B program and putting it on a sustainable path for the future. ASAP 340B was formed because our partners believe that a comprehensive set of statutory changes – outlined in our policy principles – is necessary to save the program. Multiple media outlets have raised serious questions about the actions of some covered entities in the program, and it’s Congress’ role to ensure the program meets the needs of true safety-net providers and the patients they are supposed to serve through the 340B program. We hope this process leads to a much-needed broad review of the program.”

To read ASAP 340B’s 10 policy principles click here.

###

About the Alliance to Save America’s 340B Program (ASAP 340B)

The Alliance to Save America’s 340B Program (ASAP 340B) is a partnership of Community Health Centers, patient, provider and consumer advocates, and leaders from the biopharmaceutical industry working to improve the 340B program. ASAP 340B is focused on advancing meaningful and achievable changes in support of our nation’s safety-net providers and underserved communities. To learn more, visit asap340B.org and follow us on Twitter @asap340B.

Comments


bottom of page